首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative
【24h】

Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative

机译:散发性类胶质纤维瘤病的管理:基于患者和专业知识的欧洲共识方法-肉瘤患者EuroNet和欧洲癌症/软组织研究和治疗组织以及骨肉瘤组织的倡议

获取原文
获取原文并翻译 | 示例
       

摘要

Desmoid-type fibromatosis (DF) is a rare monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. It may affect nearly all parts of the body including extremities, trunk and abdomen. Considering the variable clinical presentations, anatomic locations and biological behaviours, an individualised treatment approach is required. No established or evidence-based approach for the treatment of this neoplasm is available as of today. Therefore, we propose a consensus treatment algorithm based on a round table meeting bringing together sarcoma experts from the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) with patient advocates from Sarcoma Patients EuroNet (SPAEN). The aim of the meeting was to develop - for the first time ever - a consensus approach based on professionals' AND patients' expertise. As a fundamental prerequisite, all patients should be discussed in a multidisciplinary setting in centres or professional networks with a specific expertise in the disease. (C) 2014 Elsevier Ltd. All rights reserved.
机译:胶体样纤维瘤病(DF)是一种罕见的单克隆,成纤维细胞增生,其特征是临床过程多变且常常无法预测。它可能会影响身体的几乎所有部位,包括四肢,躯干和腹部。考虑到可变的临床表现,解剖位置和生物学行为,需要个体化的治疗方法。迄今为止,尚无成熟的或基于证据的治疗这种肿瘤的方法。因此,我们提出了一个基于圆桌会议的共识治疗算法,该会议将来自欧洲癌症研究和治疗组织(EORTC)软组织和骨肉瘤组织(STBSG)的肉瘤专家与来自肉瘤患者EuroNet(SPAEN)的患者倡导者召集在一起。会议的目的是有史以来第一次开发基于专业人员和患者的专业知识的共识方法。作为基本前提,应在具有特定疾病专业知识的中心或专业网络中,以多学科的方式讨论所有患者。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号